Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campbell N. P., Kelly J. G., Shanks R. G., Chaturvedi N. C., Strong J. E., Pantridge J. F. Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet. 1973 Aug 25;2(7826):404–407. doi: 10.1016/s0140-6736(73)92271-x. [DOI] [PubMed] [Google Scholar]
- Kelly J. G., Nimmo J., Rae R., Shanks R. G., Prescott L. F. Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol. 1973 Jul;25(7):550–553. doi: 10.1111/j.2042-7158.1973.tb09155.x. [DOI] [PubMed] [Google Scholar]
- Kiddie M. A., Royds R. B., Shaw T. R. Preliminary studies on the pharmacology of an antidysrhythmic, Kö 1173, in man. Br J Pharmacol. 1973 Mar;47(3):674P–675P. [PMC free article] [PubMed] [Google Scholar]
- Talbot R. G., Julian D. G., Prescott L. F. Long-term treatment of ventricular arrhythmias with oral mexiletine. Am Heart J. 1976 Jan;91(1):58–65. doi: 10.1016/s0002-8703(76)80435-8. [DOI] [PubMed] [Google Scholar]
